Patent ID: 11877995
Assignee: IMMUNIC AG
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  Y | IPC A

Claim 22:
23. A method of treating multiple sclerosis in a subject in need thereof, the method comprising:
a) administering to the subject at least one compound each day for 7 days at an initial daily dose; and thereafter
b) administering to the subject the at least one compound at a subsequent daily dose,
wherein the initial daily dose is about 42 μmol per day to about 63 μmol per day,
wherein the subsequent daily dose is about 84 μmol per day about 126.6 μmol per day, and
wherein the at least one compound includes 2-({3-fluoro-3′-methoxy-[1,1′-biphenyl]-4-yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid or a pharmaceutically-acceptable salt or solvate thereof.